Clinical Trial Update: Evaluation of Accu-Chek DiaPort, a Port System for Continuous Intraperitoneal Insulin Infusion, in Patients With Type I Diabetes [NA]

View source ↗

Summary

This clinical trial update reports results for Accu-Chek DiaPort, a port system for continuous intraperitoneal insulin infusion in adults with Type 1 diabetes; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Accu-Chek DiaPort

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diabetes Mellitus, Type 1 | NA | Status: COMPLETED | Results posted: 2016-03-03